- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.08. | Alteogen Inks Licensing Pact with Global Pharma Company to Develop, Commercialize Subcutaneous Biologic | ||
| 05.08. | Lilly 2Q Revenues Top $23B | ||
| 04.08. | Lilly, Amplia to Evaluate Combined Investigational Treatments for Advanced NSCLC | ||
| 04.08. | FDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi | ||
| 04.08. | Altasciences Completes R&D Lab Expansion in Pennsylvania | ||
| 04.08. | Supernus and Indivior to Merge, Creating Diversified CNS Biopharma Company | ||
| 04.08. | FUJIFILM Biotechnologies Transitions Leadership | ||
| 04.08. | Johnson & Johnson EVP Jennifer Taubert to Retire, Tom Cavanaugh Named Successor | ||
| 04.08. | Piramal Pharma Solutions Expands Peptide API Facility | ||
| 03.08. | Niagen Selects Evotec to Advance Preclinical Development of Oral Small-Molecule Candidate | ||
| 03.08. | Obsidian Therapeutics Completes Galera Therapeutics Merger with $350M Private Placement Financing | ||
| 03.08. | Plus Therapeutics Rebrands with Launch of Cerenome | ||
| 03.08. | Curium, Lantheus to Merge in Deal Worth Up to $8B | ||
| 03.08. | BioNTech Names Guido Oelkers as CEO | ||
| 03.08. | Codis Completes Acquisition of Catalent's Nottingham, UK Facility | ||
| 31.07. | AdvanCell Breaks Ground on New U.S. Headquarters & Flagship Manufacturing Facility | ||
| 31.07. | FDA Clears Ractigen IND Application for Novel saRNA Candidate in Proliferative Vitreoretinopathy | ||
| 31.07. | Kaigene Licenses KG006 to Taisho in Japan | ||
| 30.07. | miRecule, Rio Biofarma Brasil to Co-Develop Peptide Tech for Targeted RNA Delivery | ||
| 30.07. | Tasrif Pharmaceuticals Expands Intellectual Property Around Poliovirus Receptor | ||
| 30.07. | Promatix Biosciences Wins Innovate UK Grant for Cancer ADC Program | ||
| 30.07. | Ember, Alfresa to Partner on Cold Chain Quality Improvement in Japan | ||
| 30.07. | Shimadzu Launches GCMS-TQ RX Series | ||
| 30.07. | Lilly, Resilience to Invest $750M in Ohio Manufacturing | ||
| 30.07. | Johnson & Johnson Acquires Firefly Bio for $1B |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.